At the forefront of medical innovation, the Cleveland Clinic is pioneering a study that revisits the potential of psychedelics, substances traditionally linked with recreational use, as a beacon of hope for mental health treatment. This ambitious research revolves around psilocybin, the primary psychoactive component in magic mushrooms, and its capacity to address various mental health…